ArticleScientific reports2023

Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment.

Yeryung Koo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.